Market Tracker

02/17 5:16pm ET

Mesoblast Ltd (NASDAQ:MESO)

6.41
Delayed Data
As of Feb 17
 +0.0888 / +1.40%
Today’s Change
3.50
Today|||52-Week Range
10.89
+19.81%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.32
Today’s open6.57
Day’s range6.28 - 6.57
Volume33,758
Average volume (3 months)14,203
Market cap$510.5M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-467.25%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.10-0.82%
OFIXOrthofix Internation...+0.04+0.11%
CFMSConforMIS Inc-0.02-0.34%
RTIXRTI Surgical Inc+0.23+6.82%
Data as of 4:14pm ET, 02/17/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts